Children with JIA N = 90 | Healthy children N = 10 | |||
---|---|---|---|---|
Total group | No medical treatment N = 42 (46,7) | Medical treatment N = 48 (53.3) | ||
Gender, number of girls (%) | 68 (69) | 6 (60) | ||
Age at onset, years, Md (IQR) | 5.7 (2.5–11.8) | |||
Age at sampling, years, Md (IQR) | 11.6 (6.7–15.1)* | 8.4 (6.3–10.9)* | ||
Disease duration at sampling | 2.5 (0.9–5.8) | 1.8 (0.2–5.1) | 3.0 (1.6–6.7) | |
JADAS27, Md (IQR) | 4.2 (1.8–8.8) | 6.3 (2.7–11.9)** | 3.6 (0.7–5.7)** | |
ILAR category, n (%) | ||||
Oligoarticular persistent | 60 (66.7) | 31 | 29 | |
Polyarticular RF − | 15 (16.7) | 5 | 10 | |
Juvenile psoriatic arthritis | 8 (8.9) | 4 | 4 | |
Oligoarticular extended | 4 (4.4) | 1 | 3 | |
Enthesitis-related arthritis | 2 (2.2) | 1 | 1 | |
Polyarticular RF+ | 1 (1.1) | 0 | 1 | |
Medical treatment, n (%) | ||||
MTX | 27 (30) | |||
Biological agent + MTX | 11 (12.2) | |||
Biological agent | 10 (11.1) |